Viravaxx AG

Viravaxx ag email format

Verified email-pattern data for Viravaxx Ag is currently limited. You can still use the company insights and contact sections below.
Viravaxx is a drug development company dedicated to hepatitis B vaccine development with a lead vaccine candidate (VVX001) currently in phase II clinical trials: • Interim data confirm that VVX001 induces a preS-specific IgG antibody response in vaccine naïve adults and in chronically infected patients. • Abstracts presenting interim data were recently accepted for publication at the American Association for the Study of Liver Diseases (AASLD) and HepDART. • Viravaxx works with a board of international renowned hepatologists including Anna Lok, Fabien Zoulim, Florian van Bömmel, Patrick Kennedy and Peter Ferenci.

Company Details

Employees
1
Founded
-
Address
Mariannengasse 14/9, Vienna,austria
Industry
Biotechnology Research
HQ
Vienna
Looking for a particular Viravaxx AG employee's phone or email?

Viravaxx Ag Questions

Explore related pages

Related company profiles:

Top Viravaxx AG Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant